Viral Immune Pathology Diagnostics Introduces New Test for XMRV Patients and
Clinicians
-Net proceeds from test dedicated to further WPI research-
RENO, Nev. – The Whittemore Peterson Institute (WPI) has recently published a
research study
revealing the prevalence of XMRV in patients with Myalgic
Encephalomyelitis/Chronic Fatigue
Syndrome, ME/CFS or what has most recently been called, X associated
neuro-immune disease,
(XAND).
In response to an overwhelming request for a diagnostic test for XMRV,
WPI has temporarily
agreed to allow Viral Immune Pathology Diagnostics (VIP Dx) to begin offering
the identical tests that
have been extensively validated using the same technology developed by Drs.
Lombardi and Mikovits
and their colleagues as reported in Science.
VIP Dx is a small state certified laboratory in Reno, Nevada that was formed in
response to the
September 11, 2001 crisis which resulted in the cessation of blood sample
shipments between the United States and Europe. Faced with the loss of
important lab tests impacting patients with neuro-immune diseases, the
Whittemore family made the decision to support the lab in Reno.
“Our family made it possible for the lab to not only continue delivering
diagnostic tests to doctors, but
also help the WPI bring cutting edge biomarkers of disease to this field of
medicine, such as the tests for
XMRV,” said Annette Whittemore, Founder and President of WPI.
“Tests conducted
for XMRV, and
other tests that support the diagnostic process in this field, will support the
continuation of vital work at
WPI through our donation of all of our net proceeds.”
XMRV test acceptance commenced at VIP Dx this month.
For more information about the XMRV test kit, visit
www.vipdx.com.
Whittemore Peterson Institute
The Whittemore Peterson Institute for Neuro-Immune Disease exists to bring
discovery, knowledge, and
effective treatments to patients with illnesses caused by acquired dysregulation
of the immune system
and the nervous system, often resulting in lifelong disease and disability. The
WPI is the first institute in
the world dedicated to neuro-immune diseases, integrating patient treatment,
basic and clinical
research and medical education.
Donate to the WPI - click here
The WPI at the Invest in ME International ME/CFS
Conferences -